[HTML][HTML] Addiction as a brain disease revised: why it still matters, and the need for consilience

M Heilig, J MacKillop, D Martinez, J Rehm… - …, 2021 - nature.com
The view that substance addiction is a brain disease, although widely accepted in the
neuroscience community, has become subject to acerbic criticism in recent years. These …

Opioid use disorder

J Strang, ND Volkow, L Degenhardt… - Nature reviews Disease …, 2020 - nature.com
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by
activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that …

The changing opioid crisis: development, challenges and opportunities

ND Volkow, C Blanco - Molecular psychiatry, 2021 - nature.com
The current opioid epidemic is one of the most severe public health crisis in US history.
Responding to it has been difficult due to its rapidly changing nature and the severity of its …

Management of opioid use disorder in the USA: present status and future directions

C Blanco, ND Volkow - The Lancet, 2019 - thelancet.com
Opioid use disorder is characterised by the persistent use of opioids despite the adverse
consequences of its use. The disorder is associated with a range of mental and general …

Stigma at every turn: Health services experiences among people who inject drugs

CE Paquette, JL Syvertsen, RA Pollini - International Journal of Drug Policy, 2018 - Elsevier
Background People who inject drugs (PWID) encounter varying forms of stigma in health
services contexts, which can contribute to adverse outcomes. We explored the lived …

Retention of patients in opioid substitution treatment: a systematic review

AM O'Connor, G Cousins, L Durand, J Barry, F Boland - PloS one, 2020 - journals.plos.org
Background Retention in opioid substitution (OST) treatment is associated with substantial
reductions in all cause and overdose mortality. This systematic review aims to identify both …

Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder

RL Haffajee, LA Lin, ASB Bohnert… - JAMA network …, 2019 - jamanetwork.com
Importance Opioid overdose deaths in the United States continue to increase, reflecting a
growing need to treat those with opioid use disorder (OUD). Little is known about counties …

A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States

JJ Lister, A Weaver, JD Ellis, JA Himle… - The American journal …, 2020 - Taylor & Francis
Background Opioid-related deaths have risen dramatically in rural communities. Prior
studies highlight few medication treatment providers for opioid use disorder in rural …

[HTML][HTML] Policy pathways to address provider workforce barriers to buprenorphine treatment

RL Haffajee, ASB Bohnert, PA Lagisetty - American journal of preventive …, 2018 - Elsevier
At least 2.3 million people in the US have an opioid use disorder, less than 40% of whom
receive evidence-based treatment. Buprenorphine used as part of medication-assisted …

Drug policy and the public good

T Babor - 2010 - books.google.com
Drug use represents a significant burden to public health through disease, disability and
social problems, and policy makers are becoming increasingly interested in how to develop …